Skip to main content

Jeffrey B. Kindler

Equibles does not estimate personal net worth.

Get an email with a short summary when Praxis Precision Medicines, Inc. publishes a filing, an earnings call transcript or a press release.

Get PRAX alerts

About Jeffrey B. Kindler

Jeffrey B. Kindler is recorded as Board Member at Praxis Precision Medicines, Inc. (PRAX) since January 8, 2026. Praxis Precision Medicines, Inc. reported in an 8-K filed January 8, 2026 that Jeffrey B. Kindler was appointed Class II director, effective January 8, 2026. Praxis Precision Medicines, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Praxis Precision Medicines, Inc. includes Marcio Souza (CEO and Board Member), Timothy E. Kelly (CFO), Timothy Kelly (CFO) and 6 others.

“On January 8, 2026, the Board of Directors (the "Board") of the Company, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Jeffrey B. Kindler to the Board as a Class II director, effective January 8, 2026, to serve until the 2028 annual meeting of stockholders or until his successor has been duly elected and qualified.”
Praxis Precision Medicines, Inc. Form 8-K, filed January 8, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Praxis Precision Medicines, Inc.

Recent activity